Table 1.
Class of Medications | Example | Advantages | Disadvantages | Mechanism of action | References |
---|---|---|---|---|---|
Biguanidas | Metformin (Glucophag) |
Reducing hepatic glucose, fasting glycemia, Hemoglobin A1C |
Weight loss Anorexia Nausea Abdominal discomfort Diarrhea |
Reducing hepatic glucose output through inhibition of gluconeogenesis | (19, 21-24) |
Sulfonylures | Glibenclamie (Daonil), Gliclazide (Glizid( | Secreting insulin Decreasing glycemia, Hemoglobin A1C |
Weight gain Hypoglycemia |
Increasing insulin secretion regulated by ATP-sensitive potassium channels | (19, 22, 24, 25) |
Thiazolidinediones (TZDs) | Glitazones, Pioglitazone | Using glucose by increasing the insulin sensitivity in muscle, fat, and liver tissues | Weight gain Fluid retention with peripheral edema, risk for congestive heart failure |
Increasing insulin sensitivity by binding to peroxisome proliferator-activated receptors, improving blood glucose levels by preserving pancreatic beta-cell function | (19, 22, 26, 27) |
Insulin | Decreasing hemogolobin A1C, Effects on triacylglycerol and HDL cholesterol levels |
Weight gain Hypoglycemia Interactions with other medications, Cardiovascular disease |
Reducing glucose concentration by increasing glucose uptake or reducing glucose production | (22, 28-31) |